WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

First drug to slow down progress of type 1 diabetes gets approval

Teplizumab licensed for use by adults and older children in ‘breakthrough moment’

Raccontata daindependent.co.uktelegraph.co.uk

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
telegraph.co.ukStai leggendo10 mesi fa

First drug to slow down progress of type 1 diabetes gets approval

Teplizumab licensed for use by adults and older children in ‘breakthrough moment’

originale
independent.co.uk10 mesi fa

Breakthrough drug that slows onset of type 1 diabetes set for UK release

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 14 agosto 2025·independent.co.uk

    Breakthrough drug that slows onset of type 1 diabetes set for UK release

    Teplizumab can allow patients to live “normal lives” without the need for insulin injections

  2. giovedì 14 agosto 2025·telegraph.co.uk

    First drug to slow down progress of type 1 diabetes gets approval

    Teplizumab licensed for use by adults and older children in ‘breakthrough moment’